- Vaccines cause the beetus? Idk maybe.
- Tubeless pump fda approved before eoy(check out what happened to bbnx when they announced theirs). Approval of this will open a whole new market.
- Fantastic q2 earnings w/ their pay-go system as well as sales.
- There has never been a gain in September since this stock went public, so buy now while it’s still cheap!
- Matt Mikisik analyst who specializes in healthcare medical devices has a 85% profitability rating on his stocks gave this $55 price target.
Can you tell I’m not using ai to post this?